DILH
MDCO

Dai-ichi Life Holdings’s Medicines Co MDCO Stock Holding History

Dai-ichi Life Holdings’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-32,395
Closed -$1.22M – 513
2016
Q3 		$1.22M Sell
32,395
-1,617
-5% -$60.9K 0.04% 383
2016
Q2 		$1.14M Buy
+34,012
New +$1.2M 0.03% 386

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Dai-ichi Life Holdings's MDCO Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Medicines Co (MDCO) in Q4 2016, closing a stake of 32,395 shares — an estimated $1.22M sold.

Dai-ichi Life Holdings first reported a position in MDCO in Q2 2016 and held it in 2 quarters. The position peaked at $1.22M in Q3 2016. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Medicines Co position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 32,395 Medicines Co shares in Q4 2016, an estimated $1.22M.
  • Dai-ichi Life Holdings first reported a position in Medicines Co in Q2 2016 and held it in 2 quarters.
  • Dai-ichi Life Holdings's Medicines Co position peaked at $1.22M in Q3 2016.
  • 195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.